In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By End Use (Hospitals, Laboratory), By Application, By Technology (Molecular Diagnostics), By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation and Scope
                   1.2. Market Definitions
                       1.2.1. Product
                       1.2.2. Technology
                       1.2.3. Application
                       1.2.4. Test Location
                       1.2.5. End Use
                   1.3. Regional Scope
                   1.4. Estimates and Forecast Timeline
                   1.5. Research Methodology
                   1.6. Information Procurement
                       1.6.1. Purchased Database
                       1.6.2. GVR’s Internal Database
                   1.7. Details of primary research
                   1.8. Market Formulation & Validation
                   1.9. Model Details
                       1.9.1. Commodity flow analysis (Model 1)
                           1.9.1.1. Approach 1: Commodity flow approach
                       1.9.2. Volume price analysis (Model 2)
                           1.9.2.1. Approach 2: Volume price analysis
                   1.10. Research Scope and Assumptions
                       1.10.1. List of Secondary Sources
                       1.10.2. List of Primary Sources
                       1.10.3. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Drivers Analysis
                           3.2.1.1. Introduction of Technologically Advanced Products
                           3.2.1.2. Increasing Demand for PoC Testing
                           3.2.1.3. Growing Prevalence of Target Diseases
                           3.2.1.4. Increasing External Funding for R&D
                       3.2.2. Market Restraints Analysis
                           3.2.2.1. Presence of Ambiguous Regulatory Framework
                           3.2.2.2. High Capital Investment
                           3.2.2.3. High Prices of Molecular Diagnostic Tests
                       3.2.3. Market Opportunity Analysis
                       3.2.4. Supply Chain Analysis
                       3.2.5. Distribution Channel
                           3.2.5.1. Direct Sales
                           3.2.5.2. Distributors Network
                           3.2.5.3. E-commerce and Online Platforms
                           3.2.5.4. Major Distributors
                   3.3. In Vitro Diagnostics Market Analysis Tools
                       3.3.1. Porter’s Analysis
                           3.3.1.1. Bargaining power of the suppliers
                           3.3.1.2. Bargaining power of the buyers
                           3.3.1.3. Threats of substitution
                           3.3.1.4. Threats from new entrants
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Economic and Social landscape
                           3.3.2.3. Technological landscape
                           3.3.2.4. Legal landscape
                   3.4. Reimbursement Overview of IVDs and LDTs
                   3.5. Pricing Analysis
Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis
                   4.1. Segment Dashboard
                   4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Billion)
                   4.3. Instruments
                   4.4. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)Reagents
                       4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
                   4.5. Services
                       4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
                   5.1. Segment Dashboard
                   5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Billion)
                   5.3. Immunoassay
                       5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       5.3.2. Instruments
                           5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Units)
                       5.3.3. Reagents
                           5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
                       5.3.4. Services
                           5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.4. Hematology
                       5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       5.4.2. Instruments
                           5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
                       5.4.3. Reagents
                           5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
                       5.4.4. Services
                           5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.5. Clinical Chemistry
                       5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       5.5.2. Instruments
                           5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
                       5.5.3. Reagents
                           5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
                       5.5.4. Services
                           5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.6. Molecular Diagnostics
                       5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       5.6.2. Instruments
                           5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
                       5.6.3. Reagents
                           5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
                       5.6.4. Services
                           5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.7. Coagulation
                       5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       5.7.2. Instruments
                           5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
                       5.7.3. Reagents
                           5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
                       5.7.4. Services
                           5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.8. Microbiology
                       5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       5.8.2. Instruments
                           5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
                       5.8.3. Reagents
                           5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
                       5.8.4. Services
                           5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.9. Others
                       5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       5.9.2. Instruments
                           5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
                       5.9.3. Reagents
                           5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
                       5.9.4. Services
                           5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis
                   6.1. Segment Dashboard
                   6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Billion)
                   6.3. Infectious Disease
                       6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.4. Diabetes
                       6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.5. Oncology/Cancer
                       6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.6. Cardiology
                       6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.7. Nephrology
                       6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.8. Autoimmune Diseases
                       6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.9. Drug Testing
                       6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.10. Others
                       6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
                   7.1. Segment Dashboard
                   7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Billion)
                   7.3. Point of Care
                       7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.4. Home-care
                       7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.5. Others
                       7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
                   8.1. Segment Dashboard
                   8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Billion)
                   8.3. Hospitals
                       8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                   8.4. Laboratory
                       8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                   8.5. Home Care
                       8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                   8.6. Others
                       8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
                   9.1. In Vitro Diagnostics Market Share, By Region, 2024 & 2030, USD Billion
                   9.2. North America
                       9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.2.2. U.S.
                           9.2.2.1. Key Country Dynamics
                           9.2.2.2. Regulatory Landscape/Reimbursement Scenario
                           9.2.2.3. Competitive Insights
                           9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.2.3. Canada
                           9.2.3.1. Key Country Dynamics
                           9.2.3.2. Regulatory Landscape/Reimbursement Scenario
                           9.2.3.3. Competitive Insights
                           9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.2.4. Mexico
                           9.2.4.1. Key Country Dynamics
                           9.2.4.2. Regulatory Landscape/Reimbursement Scenario
                           9.2.4.3. Competitive Insights
                           9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                   9.3. Europe
                       9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.3.2. U.K.
                           9.3.2.1. Key Country Dynamics
                           9.3.2.2. Regulatory Landscape/Reimbursement Scenario
                           9.3.2.3. Competitive Insights
                           9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.3.3. Germany
                           9.3.3.1. Key Country Dynamics
                           9.3.3.2. Regulatory Landscape/Reimbursement Scenario
                           9.3.3.3. Competitive Insights
                           9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.3.4. France
                           9.3.4.1. Key Country Dynamics
                           9.3.4.2. Regulatory Landscape/Reimbursement Scenario
                           9.3.4.3. Competitive Insights
                           9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.3.5. Italy
                           9.3.5.1. Key Country Dynamics
                           9.3.5.2. Regulatory Landscape/Reimbursement Scenario
                           9.3.5.3. Competitive Insights
                           9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.3.6. Spain
                           9.3.6.1. Key Country Dynamics
                           9.3.6.2. Regulatory Landscape/Reimbursement Scenario
                           9.3.6.3. Competitive Insights
                           9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.3.7. Sweden
                           9.3.7.1. Key Country Dynamics
                           9.3.7.2. Regulatory Landscape/Reimbursement Scenario
                           9.3.7.3. Competitive Insights
                           9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.3.8. Denmark
                           9.3.8.1. Key Country Dynamics
                           9.3.8.2. Regulatory Landscape/Reimbursement Scenario
                           9.3.8.3. Competitive Insights
                           9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.3.9. Norway
                           9.3.9.1. Key Country Dynamics
                           9.3.9.2. Regulatory Landscape/Reimbursement Scenario
                           9.3.9.3. Competitive Insights
                           9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                   9.4. Asia Pacific
                       9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                       9.4.2. China
                           9.4.2.1. Key Country Dynamics
                           9.4.2.2. Regulatory Landscape/Reimbursement Scenario
                           9.4.2.3. Competitive Insights
                           9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.4.3. Japan
                           9.4.3.1. Key Country Dynamics
                           9.4.3.2. Regulatory Landscape/Reimbursement Scenario
                           9.4.3.3. Competitive Insights
                           9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.4.4. India
                           9.4.4.1. Key Country Dynamics
                           9.4.4.2. Regulatory Landscape/Reimbursement Scenario
                           9.4.4.3. Competitive Insights
                           9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.4.5. South Korea
                           9.4.5.1. Key Country Dynamics
                           9.4.5.2. Regulatory Landscape/Reimbursement Scenario
                           9.4.5.3. Competitive Insights
                           9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.4.6. Australia
                           9.4.6.1. Key Country Dynamics
                           9.4.6.2. Regulatory Landscape/Reimbursement Scenario
                           9.4.6.3. Competitive Insights
                           9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.4.7. Thailand
                           9.4.7.1. Key Country Dynamics
                           9.4.7.2. Regulatory Landscape/Reimbursement Scenario
                           9.4.7.3. Competitive Insights
                           9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                   9.5. Latin America
                       9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.5.2. Brazil
                           9.5.2.1. Key Country Dynamics
                           9.5.2.2. Regulatory Landscape/Reimbursement Scenario
                           9.5.2.3. Competitive Insights
                           9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.5.3. Argentina
                           9.5.3.1. Key Country Dynamics
                           9.5.3.2. Regulatory Landscape/Reimbursement Scenario
                           9.5.3.3. Competitive Insights
                           9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                   9.6. Middle East and Africa
                       9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.6.2. Saudi Arabia
                           9.6.2.1. Key Country Dynamics
                           9.6.2.2. Regulatory Landscape/Reimbursement Scenario
                           9.6.2.3. Competitive Insights
                           9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.6.3. UAE
                           9.6.3.1. Key Country Dynamics
                           9.6.3.2. Regulatory Landscape/Reimbursement Scenario
                           9.6.3.3. Competitive Insights
                           9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.6.4. South Africa
                           9.6.4.1. Key Country Dynamics
                           9.6.4.2. Regulatory Landscape/Reimbursement Scenario
                           9.6.4.3. Competitive Insights
                           9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
                       9.6.5. Kuwait
                           9.6.5.1. Key Country Dynamics
                           9.6.5.2. Regulatory Landscape/Reimbursement Scenario
                           9.6.5.3. Competitive Insights
                           9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
Chapter 10. Competitive Landscape
                   10.1. Recent Developments & Impact Analysis by Key Market Participants
                   10.2. Company Categorization
                   10.3. Global Company Market Share Analysis, 2024
                   10.4. Company Heat Map Analysis
                   10.5. Strategy Mapping
                       10.5.1. Expansion
                       10.5.2. Mergers & Acquisition
                       10.5.3. Partnerships & Collaborations
                       10.5.4. New Product Launches
                       10.5.5. Research And Development
                   10.6. Company Profiles
                       10.6.1. Abbott
                           10.6.1.1. Participant’s Overview
                           10.6.1.2. Financial Performance
                           10.6.1.3. Product Benchmarking
                           10.6.1.4. Recent Developments
                       10.6.2. Bio-Rad Laboratories, Inc
                           10.6.2.1. Participant’s Overview
                           10.6.2.2. Financial Performance
                           10.6.2.3. Product Benchmarking
                           10.6.2.4. Recent Developments
                       10.6.3. Siemens Healthineers AG
                           10.6.3.1. Participant’s Overview
                           10.6.3.2. Financial Performance
                           10.6.3.3. Product Benchmarking
                           10.6.3.4. Recent Developments
                       10.6.4. BIOMÉRIEUX
                           10.6.4.1. Participant’s Overview
                           10.6.4.2. Financial Performance
                           10.6.4.3. Product Benchmarking
                           10.6.4.4. Recent Developments
                       10.6.5. BD
                           10.6.5.1. Participant’s Overview
                           10.6.5.2. Financial Performance
                           10.6.5.3. Product Benchmarking
                           10.6.5.4. Recent Developments
                       10.6.6. QIAGEN
                           10.6.6.1. Participant’s Overview
                           10.6.6.2. Financial Performance
                           10.6.6.3. Product Benchmarking
                           10.6.6.4. Recent Developments
                       10.6.7. Quidel Corporation
                           10.6.7.1. Participant’s Overview
                           10.6.7.2. Financial Performance
                           10.6.7.3. Product Benchmarking
                           10.6.7.4. Recent Developments
                       10.6.8. F. Hoffmann-La Roche Ltd.
                           10.6.8.1. Participant’s Overview
                           10.6.8.2. Financial Performance
                           10.6.8.3. Product Benchmarking
                           10.6.8.4. Recent Developments
                       10.6.9. Danaher
                           10.6.9.1. Participant’s Overview
                           10.6.9.2. Financial Performance
                           10.6.9.3. Product Benchmarking
                           10.6.9.4. Recent Developments
                       10.6.10. Quest Diagnostics Incorporated
                           10.6.10.1. Participant’s Overview
                           10.6.10.2. Financial Performance
                           10.6.10.3. Product Benchmarking
                           10.6.10.4. Recent Developments
                       10.6.11. Agilent Technologies, Inc.
                           10.6.11.1. Participant’s Overview
                           10.6.11.2. Financial Performance
                           10.6.11.3. Product Benchmarking
                           10.6.11.4. Recent Developments

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global In Vitro Diagnostics Market, By Region, 2018 - 2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
Table 5 Global In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 6 Global In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
Table 7 Global In Vitro Diagnostics Market, By Application, 2018 - 2030 USD Billion
Table 8 Global In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 10 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 11 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 12 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 13 North America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 14 North America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 19 U.S. In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 21 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 23 Canada In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 24 Canada In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 26 Mexico In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 27 Mexico In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 28 Mexico In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 29 Mexico In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 30 Mexico In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 31 Europe In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 32 Europe In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 33 Europe In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 34 Europe In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 35 Europe In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 36 Europe In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 37 U.K. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 38 U.K. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 39 U.K. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 40 U.K. In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 41 U.K. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 42 Germany In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 43 Germany In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 44 Germany In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 45 Germany America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 46 Germany In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 47 France In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 48 France In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 49 France In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 50 France In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 51 France In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 52 Spain In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 53 Spain In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 54 Spain In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 55 Spain In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 56 Spain In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 57 Italy In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 58 Italy In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 59 Italy In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 60 Italy In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 61 Italy In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 62 Asia Pacific In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 63 Asia Pacific In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 64 Asia Pacific In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 65 Asia Pacific In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 66 Asia-Pacific In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 67 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 68 China In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 69 China In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 70 China In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 71 China In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 72 China In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 73 Japan In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 74 Japan In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 75 Japan In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 76 Japan In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 77 Japan In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 78 India In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 79 India In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 80 India In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 81 India In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 82 India In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 83 South Korea In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 84 South Korea In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 85 South Korea In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 86 South Korea In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 87 South Korea In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 88 Australia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 89 Australia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 90 Australia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 91 Australia In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 92 Australia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 93 Latin America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 94 Latin America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 95 Latin America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 96 Latin America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 97 Latin America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 98 Latin America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 99 Brazil In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 100 Brazil In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 101 Brazil In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 102 Brazil In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 103 Brazil In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 104 Argentina In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 105 Argentina In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 106 Argentina In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 107 Argentina In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 108 Argentina In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 109 MEA In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 110 MEA In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 111 MEA In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 112 MEA In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 113 MEA In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 114 MEA In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 115 South Africa In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 116 South Africa In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 117 South Africa In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 118 South Africa In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 119 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
Table 120 UAE In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 121 UAE In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 122 UAE In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 123 UAE In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 124 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion) million
Table 125 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 126 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 127 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
Table 128 Saudi Arabia In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 129 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 In Vitro Diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 In vitro diagnostic market snapshot
Fig. 10 Parent market outlook, 2024
Fig. 11 In vitro diagnostic market driver impact
Fig. 12 Global elderly population
Fig. 13 New cancer cases by year
Fig. 14 In vitro diagnostic market restraint impact
Fig. 15 Market entry strategy
Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 17 Porter’s five forces analysis
Fig. 18 IVD market: Product outlook and key takeaways
Fig. 19 IVD market: Products movement analysis
Fig. 20 Instruments market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 21 Reagents market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 22 Services market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 IVD market: Technology outlook and key takeaways
Fig. 24 IVD Market: Technology movement analysis
Fig. 25 Immunoassay market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 26 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
Fig. 27 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
Fig. 28 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Hematology market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 30 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
Fig. 31 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
Fig. 32 Services market for hematology estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 33 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 34 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
Fig. 35 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
Fig. 36 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 38 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
Fig. 39 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
Fig. 40 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 41 Coagulation market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 42 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
Fig. 43 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
Fig. 44 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 Microbiology market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 46 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
Fig. 47 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
Fig. 48 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 49 Others market estimates and forecast, 2018 - 2030 (USD Billion)billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million
Fig. 50 Instruments others market estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
Fig. 51 Reagents others market estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
Fig. 52 Services market for other technology estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 IVD market: Application outlook and key takeaways
Fig. 54 IVD market: Application movement analysis
Fig. 55 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 Diabetes market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 58 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 59 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 60 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 61 Drug testing market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 62 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 63 IVD market: End Use outlook and key takeaways
Fig. 64 IVD treatment market: End Use movement analysis
Fig. 65 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 66 Laboratory market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 67 Home care market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 68 Other market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 69 IVD market: test location outlook and key takeaways
Fig. 70 IVD treatment market: Test location movement analysis
Fig. 71 Point-of-care market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 72 Homecare market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 73 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 74 IVD Market: Regional outlook and key takeaways
Fig. 75 IVD market: Regional movement analysis
Fig. 76 North America
Fig. 77 North America. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 78 U.S. key country dynamics
Fig. 79 U.S. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 80 Canada key country dynamics
Fig. 81 Canada market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 82 Mexico key country dynamics
Fig. 83 Mexico market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 84 Europe
Fig. 85 Europe market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 86 U.K. key country dynamics
Fig. 87 U.K. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 88 Germany key country dynamics
Fig. 89 Germany market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 90 Spain key country dynamics
Fig. 91 Spain market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 92 France key country dynamics
Fig. 93 France market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 94 Italy key country dynamics
Fig. 95 Italy market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 96 Denmark key country dynamics
Fig. 97 Denmark market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 98 Sweden key country dynamics
Fig. 99 Sweden market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 100 Norway key country dynamics
Fig. 101 Norway market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 102 Asia Pacific
Fig. 103 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 104 Japan key country dynamics
Fig. 105 Japan market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 106 China key country dynamics
Fig. 107 China. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 108 India key country dynamics
Fig. 109 India. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 110 South Korea key country dynamics
Fig. 111 South Korea market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 112 Thailand key country dynamics
Fig. 113 Thailand market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 114 Australia key country dynamics
Fig. 115 Australia market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 116 Latin America
Fig. 117 Latin America market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 118 Brazil key country dynamics
Fig. 119 Brazil market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 120 Argentina key country dynamics
Fig. 121 Argentina market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 122 MEA
Fig. 123 MEA market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 124 South Africa key country dynamics
Fig. 125 South Africa market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 126 UAE key country dynamics
Fig. 127 UAE market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 128 Saudi Arabia key country dynamics
Fig. 129 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Fig. 130 Ansoff matrix
Fig. 131 Competition categorization
Fig. 132 Company market share analysis, 2024
Fig. 133 Global mass spectrometry company market share analysis, 2024
Fig. 134 North America mass spectrometry company market share analysis, 2024
Fig. 135 Europe mass spectrometry company market share analysis, 2024
Fig. 136 Asia Pacific mass spectrometry company market share analysis, 2024
Fig. 137 Global immunoassay company market share analysis, 2024
Fig. 138 North America immunoassay company market share analysis, 2024
Fig. 139 Europe immunoassay company market share analysis, 2024
Fig. 140 Asia Pacific immunoassay company market share analysis, 2024
Fig. 141 Global PCR company market share analysis, 2024
Fig. 142 North America PCR company market share analysis, 2024
Fig. 143 Europe PCR company market share analysis, 2024
Fig. 144 Asia Pacific PCR company market share analysis, 2024
Fig. 145 Company market position analysis
Fig. 146 Company market position analysis
Fig. 147 Company market position analysis
Fig. 148 Company profiles
Fig. 149 Regional network map